Instrument Inactif

Autres langues Tikun Olam-Cannbit Pharmaceuticals Ltd TEL AVIV STOCK EXCHANGE

Actions

Tikun Olam-Cannbit Pharmaceuticals Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	31/03
Tikun Olam-Cannbit Pharmaceuticals Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	22/08/23
Tikun Olam-Cannbit Pharmaceuticals Ltd Auditor Raises 'Going Concern' Doubt	28/03/23
Tikun Olam-Cannbit Pharmaceuticals Ltd and Ambrosia-Supherb Signs an Exclusive Partnership Agreement	19/08/21
Tikun Olam - Cannbit Pharmaceuticals Ltd Signs an Agreement with Maccabi Healthcare Services	08/07/21
Tikun Olam-Cannbit and Gynica Announce Start of A Joint Clinical Study	24/06/21
Tikun Olam Cannbit Pharmaceuticals : Canonic of Evogene Group and Tikun Olam (Israel)-Cannbit, sign production and distribution agreements for Canonic products in Israel - Evogene	25/03/21
Apex Capital Markets Ltd. acquired 23.5% stake in A.L. Capital Holdings Ltd (TASE:CPHO-M) from Apex Issuances, Investment arm for ILS 0.5 million.	28/06/17
Tamir Fishman Venture Capital II : Eucalyptus Growth Capital fund to raise $300M for late-stage Israeli companies, 12.05.15	13/05/15
Tamir Fishman Venture Capital II : Capital soars after court ruling against Teva, 28.04.15	13/05/15
Tamir Fishman Venture Capital II : Dadi Perlmutter, Rami Hadar & Tamir-Fishman Form a Partnership and Plan to Raise 300M$, 12.05.15	12/05/15

Aucun résultat pour cette recherche